The Equine Immune System

Equine Internal Medicine: Second Edition

Volumn , Issue , 2003, Pages 1-58

  Lunn, D Paul ^a   Horohov, David W ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942591483     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-169777-1/50003-2     Document Type: Chapter

References (343)

1. Abbas A, Lichtman A, Pober J Cellular and molecular immunology 2000, WB Saunders, Philadelphia, .
2. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
3. Benjamini E, Coico R, Sunshine G Immunology: a short course 2000, Wiley-Liss, New York.
4. Janeway C, Travers P, Walport M, et al. Immunobiology: the immune system in health and disease 1999, Elsevier Science, New York.
5. Oikawa MA, Kamada M, Yoshihara T, et al. Clinico-pathological analysis of foal diseases from 237 autopsy cases. Kitasato Arch Exp Med 1991, 64:149-156.
6. Coombs SL, Webbon PM Tracheal mucus transport in the horse following equine influenza vaccination. Vet Rec 1986, 119:601-602.
7. Dixon PM Respiratory mucociliary clearance in the horse in health and disease, and its pharmaceutical modification. Vet Rec 1992, 131:229-235.
8. Oikawa M, Takagi S, Anzai R, et al. Pathology of equine respiratory disease occurring in association with transport. J Comp Pathol 1995, 113:29-43.
9. Nordengrahn A, Rusvai M, Merza M, et al. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet Microbiol 1996, 51:55-68.
10. MacKay RJ Inflammation in horses. Vet Clin North Am Equine Pract 2000, 16:15-27.
11. Giguere S, Prescott JF Equine immunity to bacteria. Vet Clin North Am Equine Pract 2000, 16:29-47.
12. Grondahl G, Johannisson A, Jensen-Waern M, et al. Opsonization of yeast cells with equine iC3b, C3b, and IgG. Vet Immunol Immunopathol 2001, 80:209-223.
13. Camp CJ, Leid RW Chemotaxis of radiolabeled equine neutrophils. Am J Vet Res 1982, 43:397-401.
14. Higgins AJ, Lees P The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs. Equine Vet J 1984, 16:163-175.
15. Gibson KT, Hodge H, Whittem T Inflammatory mediators in equine synovial fluid. Aust Vet J 1996, 73:148-151.
16. Verburg KM, Maziasz TJ, Weiner E, et al. Cox-2-specific inhibitors: definition of a new therapeutic concept. Am J Ther 2001, 8:49-64.
17. Tilley SL, Coffman TM, Koller BH Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001, 108:15-23.
18. Bertolini A, Ottani A, Sandrini M Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 2001, 44:437-450.
19. Hardy J, Bertone AL, Weisbrode SE, et al. Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. Am J Vet Res 1998, 59:88-100.
20. Marr KA, Lees P, Cunningham FM Agonist-induced adherence of equine neutrophils to fibronectin- and serum-coated plastic is CD18 dependent. Vet Immunol Immunopathol 1999, 71:77-88.
21. Smith CW Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993, 71:76-87.
22. Stickle JE The neutrophil: function, disorders, and testing. Vet Clin North Am Small Anim Pract 1996, 26:1013-1021.
23. Jones SL, Sharief Y, Chilcoat CD Signaling mechanism for equine neutrophil activation by immune complexes. Vet Immunol Immunopathol 2001, 82:87-100.
24. Foster AP, Cunningham FM Differential superoxide anion generation by equine eosinophils and neutrophils. Vet Immunol Immunopathol 1997, 59:225-237.
25. Re F, Muzio M, De Rossi M, et al. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994, 179:739-743.
26. Healy DP New and emerging therapies for sepsis. Ann Pharmacother 2002, 6:648-654.
27. Steinbach F, Deeg CA, Mauel S, et al. Equine immunology: offspring of the serum horse. Immunol Today 2002, 23:223-225.
28. Wagner B, Overesch G, Sheoran AS, et al. Organization of the equine immunoglobulin heavy chain constant region genes. III. Alignment of c mu, c gamma, c epsilon and c alpha genes. Immunobiology 1998, 199:105-118.
29. Lunn DP, Holmes MA, Antczak DF, et al. Report of the Second Equine Leucocyte Antigen Workshop, Squaw Valley, Calif, July 1995. Vet Immunol Immunopathol 1998, 62:101-143.
30. Wagner B, Greiser-Wilke I, Wege AK, et al. Evolution of the six horse IGHG genes and corresponding immunoglobulin gamma heavy chains. Immunogenetics 2002, 54:353-364.
31. Gritzmacher CA Molecular aspects of heavy-chain class switching. Crit Rev Immunol 1989, 9:173-200.
32. DeKruyff RH, Rizzo LV, Umetsu DT Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol 1993, 5:421-430.
33. Xu L, Rothman P IFN-gamma represses epsilon germline transcription and subsequently downregulates switch recombination to epsilon. Int Immunol 1994, 6:515-521.
34. Siebenkotten G, Esser C, Wabl M, et al. The murine IgG1/IgE class switch program. Eur J Immunol 1992, 22:1827-1834.
35. McIntyre TM, Kehry MR, Snapper CM Novel in vitro model for high-rate IgA class switching. J Immunol 1995, 154:3156-3161.
36. Taussig MJ Molecular genetics of immunoglobulins. Immunol Suppl 1988, 1:7-15.
37. Ford J, Home W, Gibson D Light chain isotype regulation in the horse: characterization of Ig kappa genes. J Immunol 1994, 153:1099-1111.
38. Home W, Ford J, Gibson D L chain isotype regulation in horse. I. Characterization of Ig lambda genes. J Immunnol 1992, 49:3927-3936.
39. Alcover A, Alarcon B Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol 2000, 20:325-346.
40. Chen CH, Six A, Kubota T, et al. T cell receptors and T cell development. Curr Top Microbiol Immunol 1996, 212:37-53.
41. Bromley SK, Burack WR, Johnson KG, et al. The immunological synapse. Annu Rev Immunol 2001, 19:375-396.
42. Kisielow P, Miazek A Thymic selection and tolerance. Transplant Proc 1996, 28:3429-3430.
43. Antczak DF, Allen WR Maternal immunological recognition of pregnancy in equids. J Reprod Fertil Suppl 1989, 37:69-78.
44. Margulies D The major histocompatability complex. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W. Paul (Ed.).
45. Maloy WL Comparison of the primary structure of class I molecules. Immunol Res 1987, 6:11-29.
46. Ansari HA, Hediger R, Fries R, et al. Chromosomal localization of the major histocompatibility complex of the horse (ELA) by in situ hybridization. Immunogenetics 1988, 28:362-364.
47. Donaldson WL, Crump AL, Zhang CH, et al. At least two loci encode polymorphic class I MHC antigens in the horse. Anim Genet 1988, 19:379-390.
48. Zinkernagel RM, Doherty PC Immunological surveilance against altered self-components by sensitized T lymphocytes in lymphocytic choriomeningitis. Nature 1974, 251:547-548.
49. Bjorkman PJ, Saper MA, Samraoui B, et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
50. Braciale TJ, Morrison LA, Sweetser MT, et al. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev 1987, 98:95-114.
51. Monaco JJ, Nandi D The genetics of proteasomes and antigen processing. Annu Rev Genet 1995, 29:729-754.
52. Cresswell P Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994, 12:259-293.
53. Halaby DM, Mornon JP The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J Mol Evol 1998, 46:389-400.
54. Crepaldi T, Crump A, Newman M, et al. Equine T lymphocytes express MHC class II antigens. J Immunogenet 1986, 13:349-360.
55. Lunn DP, Holmes MA, Duffus WP Equine T-lymphocyte MHC II expression: variation with age and subset. Vet Immunol Immunopathol 1993, 35:225-238.
56. Frayne J, Stokes CR MHC class II positive cells and T cells in the equine endometrium throughout the oestrous cycle. Vet Immunol Immunopathol 1994, 41:55-72.
57. Steinman R Dendritic cells. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
58. Weiss A T-lymphocyte activaton. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
59. Bluestone J, Khattri R, van Seventer G Accessory modules. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W. Paul (Ed.).
60. Horohov DW, Siegel JP Lymphokines: progress and promise. Drugs 1987, 33:4289-4295.
61. Mizel SB, Farrar JJ Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors. Cell Immunol 1979, 48:433-436.
62. Hanlon AM, Jang S, Salgame P Signaling from cytokine receptors that affect Th1 responses. Front Biosci 2002, 7:D1247-D1254.
63. Bowie A, O'Neill LA The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000, 67:508-514.
64. Imada K, Leonard WJ The Jak-STAT pathway. Mol Immunol 2000, 37:1-11.
65. Leonard WJ, Lin JX Cytokine receptor signaling pathways. J Allergy Clin Immunol 2000, 105:877-888.
66. Heyninck K, Beyaert R Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol Cell Biol Res Commun 2001, 4:259-265.
67. Akgul C, Moulding DA, Edwards SW Molecular control of neutrophil apoptosis. FEBS Lett 2001, 487:318-322.
68. Sampson AP The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000, 30(suppl 1):22-27.
69. Sandersen C, Bureau F, Turlej R, et al. p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves. Vet Immunol Immunopathol 2001, 80:315-326.
70. Horohov DW Equine T-cell cytokines: protection and pathology. Vet Clin North Am Equine Pract 2000, 16:1-14.
71. Aggarwal N, Holmes MA Characterisation of equine T helper cells: demonstration of Th1- and Th2-like cells in long-term equine T-cell cultures. Res Vet Sci 1999, 66:277-279.
72. Seder R, Mosmann T Differentiation of effector phenotypes of CD4+ and CD8+ T cells. Fundamental immunology 1999, Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
73. Gilger BC, Malok E, Cutter KV, et al. Characterization of T lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet Immunol Immunopathol 1999, 71:17-28.
74. Lavoie JP, Maghni K, Desnoyers M, et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 2001, 164:1410-1413.
75. Perryman LE, McGuire TC, Torbeck RL Ontogeny of lymphocyte function in the equine fetus. Am J Vet Res 1980, 41:1197-1200.
76. Hannant D, Rossdale PD, McGladdery AJ et al: Immune responses of the equine foetus to protein antigens. Proceedings of the Sixth International Conference on Equine Infectious Diseases, Cambridge, UK, 1991. p 86.
77. Martin BR, Larson KA Immune response of the equine fetus to coliphage T2. Am J Vet Res 1973, 34:1363-1364.
78. Morgan DO, Bryans JT, Mock RE Immunoglobulins produced by the antigenised equine foetus. J Reprod Fertil Suppl 1975, 23:735-738.
79. Lydyard P, Grossi C Development of the immune system. Immunology 1993, Mosby, St Louis. I.M. Roitt, J. Brostoff, D.K. Male (Eds.).
80. Boyd RL, Tucek CL, Godfrey DI, et al. The thymic microenvironment. Immunol Today 1993, 14:445-459.
81. Godfrey DI, Zlotnik A Control points in early T-cell development. Immunol Today 1993, 14:547-553.
82. Palmer DB, Hayday A, Owen MJ Is TCR b expression an essential event in early thymocyte development?. Immunol Today 1993, 14:460-462.
83. Blanchard-Channell M, Moore PF, Stott JL Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5. Immunology 1994, 82:548-554.
84. Lunn DP, Holmes MA, Duffus WPH Three monoclonal antibodies identifying antigens on all equine T-lymphocytes, and two mutually exclusive T-lymphocyte subsets. Immunology 1991, 74:251-257.
85. Wichtel MG, Anderson KL, Johnson TV, et al. Influence of age on neutrophil function in foals. Equine Vet J 1991, 23:466-469.
86. Morris DD, Gaulin G, Strzemienski PJ, et al. Assessment of neutrophil migration, phagocytosis and bactericidal capacity in neonatal foals. Vet Immunol Immunopathol 1987, 16:173-184.
87. Hietala SK, Ardans AA Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet Immunol Immunopathol 1987, 14:279-294.
88. Bernoco M, Liu IKM, West-Ehlert CJ, et al. Chemotactic and phagocytic function of peripheral blood polymorphonuclear leucocytes in newborn foals. J Reprod Fertil Suppl 1987, 35:599-605.
89. Demmers S, Johannisson A, Grondahl G, et al. Neutrophil functions and serum IgG in growing foals. Equine Vet J 2001, 33:676-680.
90. McTaggart C, Yovich JV, Penhale J, et al. A comparison of foal and adult horse neutrophil function using flow cytometric techniques. Res Vet Sci 2001, 71:73-79.
91. Liu IK, Walsh EM, Bernoco M, et al. Bronchoalveolar lavage in the newborn foal. J Reprod Fertil Suppl 1987, 35:587-592.
92. Grondahl G, Sternberg S, Jensen-Waern M, et al. Opsonic capacity of foal serum for the two neonatal pathogens Escherichia coli and Actinobacillus equuli,. Equine Vet J 2001, 33:670-675.
93. Bernoco MM, Liu IK, Willits NH Hemolytic complement activity and concentrations of its third component during maturation of the immune response in colostrum-deprived foals. Am J Vet Res 1994, 55:928-933.
94. Lavoie JP, Spensley MS, Smith BP, et al. Complement activity and selected hematologic variables in newborn foals fed bovine colostrum. Am J Vet Res 1989, 50:1532-1536.
95. Smith R, Chaffin MK, Cohen ND, et al. Age-related changes in lymphocyte subsets of quarter horse foals. Am J Vet Res 2002, 63:531-537.
96. Flaminio MJ, Rush BR, Shuman W Peripheral blood lymphocyte subpopulations and immunoglobulin concentrations in healthy foals and foals with Rhodococcus equi pneumonia. J Vet Intern Med 1999, 13:206-212.
97. Flaminio MJ, Rush BR, Davis EG, et al. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet Immunol Immunopathol 2000, 73:267-285.
98. Sanada Y, Noda H, Nagahata H Development of lymphocyte blastogenic response in the neonatal period of foals. Zentralbl Veterinarmedizin-Reihe A 1992, 39:69-75.
99. Lunn DP, Holmes MA, Duffus WPH Equine T lymphocyte MHC II expression: variation with age and subset. Vet Immunol Immunopathol 1993, 35:225-238.
100. Jansen BC, Knoetze PC The immune response of horses to tetanus toxoid. Onderstepoort J Vet Res 1979, 46:211-216.
101. Wilson WD Vaccination of foals: British Equine Veterinary Association Conference 2001, R&W Publications, Harrogate.
102. Jeffcott LB Studies on passive immunity in the foal. J Comp Pathol 1974, 84:93-101.
103. Rouse BT The immunoglobulins of adult equine and foal sera: a quantitative study. Br Vet J 1971, 127:45-51.
104. Sellon DC Secondary immunodeficiencies of horses. Vet Clin North Am Equine Pract 2000, 16:117-130.
105. Rouse BT, Ingram DG The total protein and immunoglobulin profile of equine colostrum and milk. Immunology 1970, 19:901-907.
106. Sheoran AS, Timoney JF, Holmes MA, et al. Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am J Vet Res 2000, 61:1099-1105.
107. Jeffcott LB Studies on passive immunity in the foal. 1. Gamma-globulin and antibody variations associated with the maternal transfer of immunity and the onset of active immunity. J Comp Pathol 1974, 84:93-101.
108. Jeffcott LB Duration of permeability of the intestine to macromolecules in the newly-born foal. Vet Rec 1971, 88:340-341.
109. Holmes MA, Lunn DP A study of bovine and equine immunoglobulin levels in pony foals fed bovine colostrum. Equine Vet J 1991, 23:116-118.
110. Lavoie JP, Spensley MS, Smith BP, et al. Absorption of bovine colostral immunoglobulins G and M in newborn foals. Am J Vet Res 1989, 50:1598-1603.
111. Sheoran AS, Sponseller BT, Holmes MA, et al. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses. Vet Immunol Immunopathol 1997, 59:239-251.
112. Nelson KM, Schram BR, McGregor MW, et al. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
113. Hoffman AM, Viel L, Juniper E, et al. Clinical and endoscopic study to estimate the incidence of distal respiratory tract infection in thoroughbred foals on Ontario breeding farms. Am J Vet Res 1993, 54:1602-1607.
114. Prescott JF Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991, 4:20-34.
115. Wilson WD, Mihalyi JE, Hussey S, et al. Passive transfer of specific immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J 2001, 7:644-650.
116. Gibbs E, Wilson J, All B Studies on passive immunity and the vaccination of foals against eastern equine encephalitis in Florida. Equine Infect Dis 1988, 5:201-205.
117. Galan JE, Timoney JF, Lengemann FW Passive transfer of mucosal antibody to Streptococcus equi in the foal. Infect Immun 1986, 54:202-206.
118. van Maanen C, Bruin G, de Boer Luijtze E, et al. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet Q 1992, 14:13-17.
119. Oirschot JT, Bruin G, Boer-Luytze E, et al. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. J Vet Med 1991, 38:391-396.
120. Adkins B T-cell function in newborn mice and humans. Immunol Today 1999, 20:330-335.
121. Ridge JP, Fuchs EJ, Matzinger P Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996, 271:1723-1726. [see comments].
122. Forsthuber T, Yip HC, Lehmann PV Induction of TH1 and TH2 immunity in neonatal mice. Science 1996, 271:1728-1730.
123. Sarzotti M, Robbins DS, Hoffman PM Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996, 271:1726-1728.
124. Coombs RRA, Gell PGH Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical aspects of immunology 1975, Blackwell, Oxford. P.G.H. Gell, R.R.A. Coombs, P. Lachman (Eds.).
125. Janeway CA, Travers P, Walport M, et al. Allergy and hypersensitivity immunobiology 2002, Garland Publishing, New York.
126. Swiderski CE Hypersensitivity disorders in horses. Vet Clin North Am Equine Pract 2000, 16:131-151.
127. McAleese SM, Halliwell RE, Miller HR Cloning and sequencing of the horse and sheep high-affinity IgE receptor alpha chain cDNA. Immunogenetics 2000, 51:878-881.
128. Watson JL, Jackson KA, King DP, et al. Molecular cloning and sequencing of the low-affinity IgE receptor (CD23) for horse and cattle. Vet Immunol Immunopathol 2000, 73:323-329.
129. Klei TR Equine immunity to parasites. Vet Clin North Am Equine Pract 2000, 6:69-78.
130. Forsthuber T, Yip HC, Lehmann PV Induction of TH1 and TH2 immunity in neonatal mice. Science 1996, 271:1728-1730.
131. Blue JT, Dinsmore RP, Anderson KL Immune-mediated hemolytic anemia induced by penicillin in horses. Cornell Vet 1987, 77:263-276.
132. Suter M, Fey H Further purification and characterization of horse IgE. Vet Immunol Immunopathol 1983, 4:545-553.
133. Matthews AG, Imlah P, McPherson EA A reagin-like antibody in horse serum. 1. Occurrence and some biological properties. Vet Res Commun 1983, 6:13-23.
134. Wagner B, Siebenkotten G, Radbruch A, et al. Nucleotide sequence and restriction fragment length polymorphisms of the equine Cvarepsilon gene. Vet Immunol Immunopathol 2001, 82:193-202.
135. Navarro P, Barbis DP, Antczak D, et al. The complete cDNA and deduced amino acid sequence of equine IgE. Mol Immunol 1995, 32:1-8.
136. Marti E, Szalai G, Bucher K, et al. Partial sequence of the equine immunoglobulin epsilon heavy chain cDNA. Vet Immunol Immunopathol 1995, 47:363-367.
137. Halliwell RE, McGorum BC, Irving P, et al. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Vet Immunol Immunopathol 1993, 38:201-215.
138. Halliwell RE, Hines MT Studies on equine recurrent uveitis. I. Levels of immunoglobulin and albumin in the aqueous humor of horses with and without intraocular disease. Curr Eye Res 1985, 4:1023-1031.
139. Marti E, Peveri P, Griot-Wenk M, et al. Chicken antibodies to a recombinant fragment of the equine immunoglobulin epsilon heavy-chain recognising native horse IgE. Vet Immunol Immunopathol 1997, 59:253-270.
140. van der Haegen A, Griot-Wenk M, Welle M, et al. Immunoglobulin-E-bearing cells in skin biopsies of horses with insect bite hypersensitivity. Equine Vet J 2001, 33:699-706.
141. Wilson AD, Harwood LJ, Bjornsdottir S, et al. Detection of IgG and IgE serum antibodies to Culicoides salivary gland antigens in horses with insect dermal hypersensitivity (sweet itch). Equine Vet J 2001, 33:707-713.
142. Eder C, Curik I, Brem G, et al. Influence of environmental and genetic factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses. Equine Vet J 2001, 33:714-720.
143. Eder C, Crameri R, Mayer C, et al. Allergen specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 2000, 73:241-253.
144. Steinbach F, Deeg CA, Mauel S, et al. Equine immunology: offspring of the serum horse. Immunol Today 2002, 23:223-225.
145. Hanna CJ, Eyre P, Wells PW, et al. Equine immunology. 2. Immunopharmacology: biochemical basis of hypersensitivity. Equine Vet J 1982, 14:16-24.
146. Nielsen IL, Jacobs KA, Huntington PJ, et al. Adverse reaction to procaine penicillin G in horses. Aust Vet J 1988, 65:181-185.
147. Kurotaki T, Narayama K, Oyamada T, et al. Immunopathological study on equine insect hypersensitivity ("kasen") in Japan. J Comp Pathol 1994, 110:145-152.
148. Lazary S, Marti E, Szalai G, et al. Studies on the frequency and associations of equine leucocyte antigens in sarcoid and summer dermatitis. Anim Genet 1994, 25(suppl 1):75-80.
149. Marti E, Gerber H, Lazary S On the genetic basis of equine allergic diseases. II. Insect bite dermal hypersensitivity. Equine Vet J 1992, 24:113-117.
150. Robinson NE, Derksen FJ, Olszewski MA, et al. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1995, 152:283-306.
151. Schmallenbach KH, Rahman I, Sasse HH, et al. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998, 66:245-256.
152. Franchini M, Gilli U, Akens MK, et al. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998, 66:53-65.
153. Franchini M, Gill U, von Fellenberg R, et al. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res 2000, 61:1369-1374.
154. Sandersen C, Bureau F, Turlej R, et al. p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves. Vet Immunol Immunopathol 2001, 80:315-326.
155. Traub-Dargatz JL, McClure JJ, Koch C, et al. Neonatal isoerythrolysis in mule foals. J Am Vet Med Assoc 1995, 206:67-70.
156. McClure JJ, Koch C, Traub-Dargatz J Characterization of a red blood cell antigen in donkeys and mules associated with neonatal isoerythrolysis. Anim Genet 1994, 25:119-120.
157. Buechner-Maxwell V, Scott MA, Godber L, et al. Neonatal alloimmune thrombocytopenia in a quarter horse foal. J Vet Intern Med 1997, 11:304-308.
158. Ramirez S, Gaunt SD, McClure JJ, et al. Detection and effects on platelet function of anti-platelet antibody in mule foals with experimentally induced neonatal alloimmune thrombocytopenia. J Vet Intern Med 1999, 13:534-539.
159. Galan JE, Timoney JF Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi. J Immunol 1985, 135:3134-3137.
160. Divers TJ, Timoney JF, Lewis RM, et al. Equine glomerulonephritis and renal failure associated with complexes of group-C streptococcal antigen and IgG antibody. Vet Immunol Immunopathol 1992, 32:93-102.
161. Hines MT Immunologically mediated ocular disease in the horse. Vet Clin North Am Large Anim Pract 1984, 6:501-512. [review; 47 references].
162. Deeg CA, Kaspers B, Gerhards H, et al. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci 2001, 42:393-398.
163. Davidson MG, Nasisse MP, Roberts SM Immunodiagnosis of leptospiral uveitis in two horses. Equine Vet J 1987, 19:155-157.
164. Faber NA, Crawford M, LeFebvre RB, et al. Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis. J Clin Microbiol 2000, 38:2731-2733.
165. Parma AE, Fernandez AS, Santisteban CG, et al. Tears and aqueous humor from horses inoculated with Leptospira contain antibodies which bind to cornea. Vet Immunol Immunopathol 1987, 14:181-185.
166. Gilger BC, Malok E, Cutter KV, et al. Characterization of T lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet Immunol Immunopathol 1999, 71:17-28.
167. McClure JJ Equine autoimmunity. Vet Clin North Am Equine Pract 2000, 16:153-164.
168. Wilkerson MJ, Davis E, Shuman W, et al. Isotype-specific antibodies in horses and dogs with immune-mediated hemolytic anemia. J Vet Intern Med 2000, 14:190-196.
169. Geor RJ, Clark EG, Haines DM Systemic lupus erythematosus in a filly. J Am Vet Med Assoc 1990, 197:1489-1492.
170. Pfeiffer CJ, Spurlock S, Ball M Ultrastructural aspects of equine pemphigus foliaceus-like dermatitis: report of cases. J Submicrosc Cytol Pathol 1988, 20:453-461.
171. Fordyce PS, Edington N, Bridges GC, et al. Use of an ELISA in the differential diagnosis of cauda equina neuritis and other equine neuropathies. Equine Vet J 1987, 19:55-59.
172. Wright JA, Fordyce P, Edington N Neuritis of the cauda equina in the horse. J Comp Pathol 1987, 97:667-675.
173. Kadlubowski M, Ingram PL Circulating antibodies to the neuritogenic myelin protein, P2, in neuritis of the cauda equina of the horse. Nature 1981, 293:299-300.
174. Piercy RJ, Swardson CJ, Hinchcliff KW Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses. J Am Vet Med Assoc 1998, 212:244-247.
175. Woods PR, Campbell G, Cowell RL Nonregenerative anaemia associated with administration of recombinant human erythropoetin to a thoroughbred racehore. Equine Vet J 1997, 29:326-328.
176. Perryman LE Primary immunodeficiencies of horses. Vet Clin North Am Equine Pract 2000, 16:105-116.
177. Sellon DC Secondary immunodeficiencies of horses. Vet Clin North Am Equine Pract 2000, 16:117-130.
178. Halliwell REW, Gorman NT Diseases associated with immunodeficiency. Veterinary clinical immunology 1989, WB Saunders, Philadelphia. R.E.W. Halliwell, N.T. Gorman (Eds.).
179. Clabough DL, Levine JF, Grant GL, et al. Factors associated with failure of passive transfer of colostral antibodies in standardbred foals. J Vet Intern Med 1991, 5:335-340.
180. Stoneham SJ, Wingfield Digby NJ, Ricketts SW Failure of passive transfer of colostral immunity in the foal: incidence, and the effect of stud management and plasma transfusions. Vet Rec 1991, 128:416-419.
181. Raidal SL The incidence and consequences of failure of passive transfer of immunity on a thoroughbred breeding farm. Aust Vet J 1996, 73:201-206.
182. Shin EK, Perryman LE, Meek K A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J Immunol 1997, 158:3565-3569.
183. Prescott JF Immunodeficiency and serious pneumonia in foals: the plot thickens. Equine Vet J 1993, 25:88-89.
184. Lunn DP, Hannant D, Horohov DW Immunology of horses and donkeys. Handbook of vertebrate immunology 1998, Academic Press, San Diego. P.-P. Pastoret, P. Griebel, H. Bazin (Eds.).
185. Riggs MW Evaluation of foals for immune deficiency disorders. Vet Clin North Am Equine Pract 1987, 3:515-528.
186. Gorman NT, Halliwell EW Immunoglobulin quantitation and clinical interpretation. Veterinary clinical immunology 1989, WB Saunders, Philadelphia. E.W. Halliwell, N.T. Gorman (Eds.).
187. Flaminio MJ, Rush BR, Shuman W Peripheral blood lymphocyte subpopulations and immunoglobulin concentrations in healthy foals and foals with Rhodococcus equi pneumonia. J Vet Intern Med 1999, 13:206-212.
188. McFarlane D, Sellon DC, Gibbs SA Age-related quantitative alterations in lymphocyte subsets and immunoglobulin isotypes in healthy horses. Am J Vet Res 2001, 62:1413-1417.
189. Sheoran AS, Timoney JF, Holmes MA, et al. Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am J Vet Res 2000, 61:1099-1105.
190. Leblanc MM Immunologic considerations. Equine clinical neonatology 1990, Lea and Febiger, Philadelphia. A.M. Koterba, W.H. Drummond, P.C. Kosch (Eds.).
191. Clabough DL, Conboy HS, Roberts MC Comparison of four screening techniques for the diagnosis of equine neonatal hypogammaglobulinemia. J Am Vet Med Assoc 1989, 194:1717-1720.
192. Beetson SA, Hilbert BJ, Mills JN The use of the glutaraldehyde coagulation test for the detection of hypogammaglobulinaemia in neonatal foals. Aust Vet J 1986, 62:279-281.
193. McClure JT, DeLuca JL, Miller J Comparison of five screening tests for detection of failure of passive transfer in foals. J Vet Intern Med: ACVIM 20th Annual Veterinary Medical Forum Abstract Program 2002, 16:336.
194. McGuire TC, Perryman LE, Davis WC Analysis of serum and lymphocyte surface IgM of healthy and immunodeficient horses with monoclonal antibodies. Am J Vet Res 1983, 44:1284-1288.
195. Collatos C Lymphoproliferative and myeloproliferative disorders. Current therapy in equine medicine 1992, WB Saunders, Philadelphia. ed 3. N.E. Robinson (Ed.).
196. Lunn DP, Holmes MA, Antczak DF, et al. Report of the Second Equine Leucocyte Antigen Workshop. Vet Immunol Immunopathol 1998, 42:3-60.
197. Akens MK, Holznagel E, Franchini M, et al. Comparative analysis of equine lymphocyte subsets in whole blood and gradient-purified samples. Vet Immunol Immunopathol 1997, 58:231-237.
198. Kidd PG, Vogt RF Report of the workshop on the evaluation of T-cell subsets during HIV infection and AIDS. Clin Immunol Immunopathol 1989, 52:3-9.
199. Stewart C Clinical applications of flow cytometry. Cancer 1992, 69:1543-1552.
200. McClure JT, Fiste M, Sharkey L, et al. Immunophenotypic classification of leukemia in three horses. J Vet Intern Med 2001, 15:144-152.
201. Lunn DP, Holmes MA, Gibson J, et al. Haematological changes and equine lymphocyte subpopulation kinetics during primary infection and attempted re-infection of specific pathogen free foals with EHV-1. Equine Vet J Suppl 1991, 12:35-41.
202. Kydd JH, Hannant D, Mumford JA Residence and recruitment of leucocytes to the equine lung after EHV-1 infection. Vet Immunol Immunopathol 1996, 52:15-26.
203. Dascanio JJ, Zhang CH, Antczak DF, et al. Differentiation of chronic lymphocytic leukemia in the horse. J Vet Intern Med 1992, 6:225-229.
204. Flaminio MJ, Rush BR, Davis EG, et al. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet Immunol Immunopathol 2000, 73:267-285.
205. Smith R, Chaffin MK, Cohen ND, et al. Age-related changes in lymphocyte subsets of Quarter horse foals. Am J Vet Res 2002, 63:531-537.
206. Patton EA, Soboll G, Coombs D et al: Evaluation of T cell proliferative responses following EHV-1 infection. Conference of Research Workers in Animal Diseases, St. Louis, 2001.
207. McClure JT, Lunn DP, McGuirk SM Combined immunodeficiency in 3 foals. Equine Vet Educ 1993, 5:14-18.
208. Hutchison JM, Garry FB, Belknap EB, et al. Prospective characterization of the clinicopathologic and immunologic features of an immunodeficiency syndrome affecting juvenile llamas. Vet Immunol Immunopathol 1995, 49:209-227.
209. Slack JA, Risdahl JM, Valberg S, et al. Effects of corticosteroids on equine IgG sub-isotype responses to vaccination. Am J Vet Res 1997, 61:1530-1533.
210. Bernoco M, Liu IK, Wuest Ehlert CJ, et al. Chemotactic and phagocytic function of peripheral blood polymorphonuclear leucocytes in newborn foals. J Reprod Fertil Suppl 1987, 35:599-605.
211. Flaminio MJ, Rush BR, Shuman W Immunologic function in horses after non-specific immunostimulant administration. Vet Immunol Immunopathol 1998, 63:303-315.
212. Morris DD, Gaulin G, Strzemienski PJ, et al. Assessment of neutrophil migration, phagocytosis and bactericidal capacity in neonatal foals. Vet Immunol Immunopathol 1987, 16:173-184.
213. Zink MC, Yager JA, Prescott JF, et al. In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals. Am J Vet Res 1985, 46:2171-2174.
214. Foerster RJ, Wolf G Phagocytosis of opsonized fluorescent microspheres by equine polymorphonuclear leukocytes. Zentralbl Veterinarmed B 1990, 37:481-490.
215. Johannisson A, Grondahl G, Demmers S, et al. Flow-cytometric studies of the phagocytic capacities of equine neutrophils. Acta Vet Scand 1995, 36:553-562.
216. Raidal SL, Bailey GD, Love DN The flow cytometric evaluation of phagocytosis by equine peripheral blood neutrophils and pulmonary alveolar macrophages. Vet J 1998, 156:107-116.
217. Raidal SL, Bailey GD, Love DN Flow cytometric determination of oxidative burst activity of equine peripheral blood and bronchoalveolar lavage-derived leucocytes. Vet J 1998, 156:117-126.
218. Grondahl G, Sternberg S, Jensen-Waern M, et al. Opsonic capacity of foal serum for the two neonatal pathogens Escherichia coli and Actinobacillus equuli. Equine Vet J 2001, 33:670-675.
219. Demmers S, Johannisson A, Grondahl G, et al. Neutrophil functions and serum IgG in growing foals. Equine Vet J 2001, 33:676-680.
220. McTaggart C, Yovich JV, Penhale J, et al. A comparison of foal and adult horse neutrophil function using flow cytometric techniques. Res Vet Sci 2001, 71:73-79.
221. Raidal SL, Rose RJ, Love DN Effects of training on resting peripheral blood and BAL-derived leucocyte function in horses. Equine Vet J 2001, 33:238-243.
222. Hormanski CE, Truax R, Pourciau SS, et al. Induction of lymphokine-activated killer cells of equine origin: specificity for equine target cells. Vet Immunol Immunopathol 1992, 32:25-36.
223. Horohov DW, Keadle TL, Pourciau SS, et al. Mechanism of exercise-induced augmentation of lymphokine activated killer (LAK) cell activity in the horse. Vet Immunol Immunopathol 1996, 53:221-233.
224. Nunokawa Y, Fujinaga T, Taira T, et al. Evaluation of serum amyloid A protein as an acute-phase reactive protein in horses. J Vet Med Sci 1993, 55:1011-1016.
225. Okumura M, Fujinaga T, Yamashita K, et al. Isolation, characterization, and quantitative analysis of ceruloplasmin from horses. Am J Vet Res 1991, 52:1979-1985.
226. Takiguchi M, Fujinaga T, Naiki M, et al. Isolation, characterization, and quantitative analysis of C-reactive protein from horses. Am J Vet Res 1990, 51:1215-1220.
227. Topper MJ, Prasse KW Analysis of coagulation proteins as acute-phase reactants in horses with colic. Am J Vet Res 1998, 59:542-545.
228. Yamashita K, Fujinaga T, Okumura M, et al. Serum C-reactive protein (CRP) in horses: the effect of aging, sex, delivery and inflammations on its concentration. J Vet Med Sci 1991, 53:1019-1024.
229. Reis KJ A hemolytic assay for the measurement of equine complement. Vet Immunol Immunopathol 1989, 23:129-137.
230. Grondahl G, Johannisson A, Jensen-Waern M, et al. Opsonization of yeast cells with equine iC3b, C3b, and IgG. Vet Immunol Immunopathol 2001, 80:209-223.
231. Lavoie JP, Spensley MS, Smith BP, et al. Complement activity and selected hematologic variables in newborn foals fed bovine colostrum. Am J Vet Res 1989, 50:1532-1536.
232. McGuire TC, Poppie MJ Hypogammaglobulinemia and thymic hypoplasia in horses: a primary combined immunodeficiency disorder. Infect Immun 1973, 8:272-277.
233. McGuire TC, Poppie MJ, Banks KL Combined (B- and T-lymphocyte) immunodeficiency: a fatal genetic disease in Arabian foals. J Am Vet Med Assoc 1974, 164:70-76.
234. Wiler R, Leber R, Moore BB, et al. Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci U S A 1995, 92:11485-11489.
235. Poppie MJ, McGuire TC Combined immunodeficiency in foals of Arabian breeding: evaluation of mode of inheritance and estimation of prevalence of affected foals and carrier mares and stallions. J Am Vet Med Assoc 1977, 170:31-33.
236. Bernoco D, Bailey E Frequency of the SCID gene among Arabian horses in the USA. Anim Genet 1998, 29:41-42.
237. Ding Q, Bramble L, Yuzbasiyan-Gurkan V, et al. DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia. Gene 2002, 283:263-269.
238. Perryman LE, McGuire TC, Crawford TB Maintenance of foals with combined immunodeficiency: causes and control of secondary infections. Am J Vet Res 1978, 39:1043-1047.
239. Bjorneby JM, Leach DR, Perryman LE Persistent cryptosporidiosis in horses with severe combined immunodeficiency. Infect Immun 1991, 59:3823-3826.
240. Perryman LE, Bue CM, Magnuson NS, et al. Immunologic reconstitution of foals with combined immunodeficiency. Vet Immunol Immunopathol 1987, 17:495-508.
241. Perryman LE, McGuire TC, Torbeck RL Ontogeny of lymphocyte function in the equine fetus. Am J Vet Res 1980, 41:1197-1200.
242. Holliman A, Scholes SP Possible immune deficiency in Fell ponies. Vet Rec 1995, 137:176.
243. Scholes SF, Holliman A, May PD, et al. A syndrome of anaemia, immunodeficiency and peripheral ganglionopathy in Fell pony foals. Vet Rec 1998, 142:128-134.
244. Richards AJ, Kelly DF, Knottenbelt DC, et al. Anaemia, diarrhoea and opportunistic infections in Fell ponies. Equine Vet J 2000, 32:386-391.
245. Bell SC, Savidge C, Taylor P, et al. An immunodeficiency in Fell ponies: a preliminary study into cellular responses. Equine Vet J 2001, 33:687-692.
246. Perryman LE, McGuire TC, Hilbert BJ Selective immunoglobulin M deficiency in foals. J Am Vet Med Assoc 1977, 170:212-215.
247. Weldon AD, Zhang C, Antczak DF, et al. Selective IgM deficiency and abnormal B cell response in a foal. J Am Vet Med Assoc 1992, 201:1396-1398.
248. Perryman LE, McGuire TC Evaluation for immune system failures in horses and ponies. J Am Vet Med Assoc 1980, 176:1374-1377.
249. Boy MG, Zhang C, Antczak DF, et al. Unusual selective immunoglobulin deficiency in an Arabian foal. J Vet Intern Med 1992, 6:201-205.
250. McGuire TC, Poppie MJ, Banks KL Hypogammaglobulinaemia predisposing to infection in foals. J Am Vet Med Assoc 1975, 166:71-75.
251. Deem DA, Traver DS, Thacker HL, et al. Agammaglobulinaemia in a horse. J Am Vet Med Assoc 1979, 175:469-472.
252. Banks KL, McGuire TC, Jerrells R Absence of B lymphocytes in a horse with primary agammaglobulinaemia. Clin Immunol Immunopathol 1976, 5:282-290.
253. McGuire TC, Crawford TB, Hallowell AL, et al. Failure of colostral immunoglobulin transfer as an explanation for most infections and deaths of neonatal foals. J Am Vet Med Assoc 1977, 170:1302-1304.
254. Koterba AM, Brewer BD, Tarplee FA Clinical and clinicopathological characteristics of the septicaemic neonatal foal: review of 38 cases. Equine Vet J 1984, 16:376-382.
255. Jeffcott LB Studies on passive immunity in the foal. J Comp Pathol 1974, 84:93-101.
256. Rouse BT The immunoglobulins of adult equine and foal sera: a quantitative study. Br Vet J 1971, 127:45-51.
257. Rouse BT, Ingram DG The total protein and immunoglobulin profile of equine colostrum and milk. Immunology 1970, 19:901-907.
258. Jeffcott LB Studies on passive immunity in the foal. 1. Gamma-globulin and antibody variations associated with the maternal transfer of immunity and the onset of active immunity. J Comp Pathol 1974, 84:93-101.
259. Morris DD, Meirs DA, Merryman GS Passive transfer failure in horses: incidence and causative factors on a breeding farm. Am J Vet Res 1985, 46:2294-2299.
260. Leblanc MM, Tran T, Baldwin JL, et al. Factors that influence passive transfer of immunoglobulins in foals. J Am Vet Med Assoc 1992, 200:179-183.
261. Le Jan C Cellular components of mammary secretions and neonatal immunity: a review. Vet Res 1996, 27:403-417.
262. Xu RJ Development of the newborn GI tract and its relation to colostrum/milk intake: a review. Reprod Fertil Dev 1996, 8:35-48.
263. Wilson WD, Mihalyi JE, Hussey S, et al. Passive transfer of specific immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J 2001, 7:644-650.
264. Pearson RC, Hallowell AL, Bayly WM, et al. Times of appearance and disappearance of colostral IgG in the mare. Am J Vet Res 1984, 45:186-190.
265. Townsend HG, Tabel H, Bristol FM Induction of parturition in mares: effect on passive transfer of immunity to foals. J Am Vet Med Assoc 1983, 182:255-257.
266. Lavoie JP, Spensley MS, Smith BP, et al. Colostral volume and immunoglobulin G and M determinations in mares. Am J Vet Res 1989, 50:466-470.
267. Rumbaugh GE, Ardans AA, Ginno D, et al. Measurement of neonatal equine immunoglobulins for assessment of colostral immunoglobulin transfer: comparison of single radial immunodiffusion with the zinc sulfate turbidity test, serum electrophoresis, refractometry for total serum protein, and the sodium sulfite precipitation test. J Am Vet Med Assoc 1978, 172:321-325.
268. Holmes MA, Lunn DP A study of bovine and equine immunoglobulin levels in pony foals fed bovine colostrum. Equine Vet J 1991, 23:116-118.
269. Hines MT, Schott HC, Bayly WM, et al. Exercise and immunity: a review with emphasis on the horse. J Vet Intern Med 1996, 10:280-289.
270. Horohov DW, Dimock A, Guirnalda P, et al. Effect of exercise on the immune response of young and old horses. Am J Vet Res 1999, 60:643-647.
271. Nesse LL, Johansen GI, Blom AK Effects of racing on lymphocyte proliferation in horses. Am J Vet Res 2002, 63:528-530.
272. Wong CW, Smith SE, Thong YH, et al. Effects of exercise stress on various immune functions in horses. Am J Vet Res 1992, 53:1414-1417.
273. Wong CW, Thompson HL, Thong YH, et al. Effect of strenuous exercise stress on chemiluminescence response of equine alveolar macrophages. Equine Vet J 1990, 22:33-35.
274. Folsom RW, Littlefield-Chabaud MA, French DD, et al. Exercise alters the immune response to equine influenza virus and increases susceptibility to infection. Equine Vet J 2001, 33:664-669.
275. Gross DK, Hinchcliff KW, French PS, et al. Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Vet J 1998, 30:489-497.
276. Hoffman AM, Viel L, Prescott JF Microbiologic changes during antimicrobial treatment and rate of relapse of distal respiratory tract infections in foals. Am J Vet Res 1993, 54:1608-1614.
277. Horohov DW, Kydd JH, Hannant D The effect of aging on T cell responses in the horse. Dev Comp Immunol 2002, 26:121-128.
278. Furr MO, Crisman MV, Robertson J, et al. Immunodeficiency associated with lymphosarcoma in a horse. J Am Vet Med Assoc 1992, 201:307-309.
279. Dopson LC, Reed SM, Roth JA, et al. Immunosuppression associated with lymphosarcoma in two horses. J Am Vet Med Assoc 1983, 182:1239-1241.
280. Buechner-Maxwell V, Zhang C, Robertson J, et al. Intravascular leukostasis and systemic aspergillosis in a horse with subleukemic acute myelomonocytic leukemia. J Vet Intern Med 1994, 8:258-263.
281. Tumas DB, Hines MT, Perryman LE, et al. Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses. J Gen Virol 1994, 75:959-968.
282. Gibson JS, Slater JD, Field HJ The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals. Virology 1992, 189:317-319.
283. Mair TS Bacterial pneumonia associated with corticosteroid therapy in three horses. Vet Rec 1996, 138:205-207.
284. DeKruyff RH, Fang Y, Umetsu DT Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol 1998, 160:2231-2237.
285. Ramierz F, Fowell DJ, Puklavec M, et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996, 156:2406-2412.
286. Allen GP, Kydd JH, Slater JD, et al. Advances in understanding of the pathogenesis, epidemiology, and immunological control of equid herpesvirus abortion. Equine infectious diseases VIII: Proceedings of the Eighth International Conference, Dubai, 23rd-26th March 1998 1999, R & W Publications, Newmarket. U. Wernery, J.F. Wade, J.A. Mumford (Eds.).
287. Bryans JT, Allen GP Herpesviral diseases of the horse. Herpesvirus diseases of cattle, horses, and pigs 1989, Kluwer Academic, Boston. G. Wittmann (Ed.).
288. McClure JJ, Addison JD, Miller RI Immunodeficiency manifested by oral candidiasis and bacterial septicemia in foals. J Am Vet Med Assoc 1985, 186:1195-1197.
289. Freestone JF, Hietala S, Moulton J, et al. Acquired immunodeficiency in a seven-year-old horse. J Am Vet Med Assoc 1987, 190:689-691.
290. Janeway CA, Travers P, Walport M, et al. Manipulation of the immune response. Immunobiology 2002, Garland Publishing, New York.
291. Wilckens T, De Rijk R Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997, 18:418-424. (review; 74 references).
292. Slack JA, Risdahl JM, Valberg S, et al. Effects of corticosteroids on equine IgG sub-isotype responses to vaccination. Am J Vet Res 1997, 61:1530-1533.
293. Blotta MH, DeKruyff RH, Umetsu DT Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997, 158:5589-5595.
294. Franchimont D, Louis E, Dewe W, et al. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept 1998, 73:59-65.
295. DeKruyff RH, Fang Y, Umetsu DT Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol 1998, 160:2231-2237.
296. Ramierz F, Fowell DJ, Puklavec M, et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996, 156:2406-2412.
297. Morris DD, Strzemienski PJ, Gaulin G, et al. The effects of corticosteroid administration on the migration, phagocytosis and bactericidal capacity of equine neutrophils. Cornell Vet 1988, 78:243-252.
298. Burton JL, Kehrli ME, Kapil S, et al. Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol 1995, 57:317-325.
299. Mair TS Bacterial pneumonia associated with corticosteroid therapy in three horses. Vet Rec 1996, 138:205-207.
300. Kono Y, Hirasawa K, Fukunaga Y, et al. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl Inst Anim Health Q 1976, 16:8-15.
301. Tumas DB, Hines MT, Perryman LE, et al. Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses. J Gen Virol 1994, 75:959-968.
302. Gibson JS, Slater JD, Awan AR, et al. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol 1992, 123:351-366.
303. Messer NT, Arnold K Immune-mediated hemolytic anemia in a horse. J Am Vet Med Assoc 1991, 198:1415-1416.
304. Humber KA, Beech J, Cudd TA, et al. Azathioprine for treatment of immune-mediated thrombocytopenia in two horses. J Am Vet Med Assoc 1991, 199:591-594.
305. Gratzek AT, Kaswan RL, Martin CL, et al. Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases. Equine Vet J 1995, 27:327-333.
306. Gilger BC, Wilkie DA, Davidson MG, et al. Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis. Am J Vet Res 2001, 62:1892-1896.
307. Gilger BC, Malok E, Stewart T, et al. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet Immunol Immunopathol 2000, 76:239-255.
308. Dwyer JM Immunoglobulins in autoimmunity: history and mechanisms of action. Clin Exp Rheumatol 1996, 14:S3-S7.
309. Dwyer JM Manipulating the immune system with immune globulin. N Engl J Med 1992, 326:107-116.
310. Dietrich G, Kaveri SV, Kazatchkine MD Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992, 62:S73-S81.
311. Vassilev T, Kazatchkine MD Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases. Ther Apher 1997, 1:38-41.
312. Imbach P, Akatsuka J, Blanchette V, et al. Immunothrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995, 154:S60-S64.
313. Colagiuri S, Leong GM, Thayer Z, et al. Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. Clin Exp Rheumatol 1996, 14:S93-S97.
314. Moore BR Clinical application of interferons in large animal medicine. J Am Vet Med Assoc 1996, 208:1711-1715. (review).
315. Rush BR, Flaminio MJ Immunomodulation in horses. Vet Clin North Am Equine Pract 2000, 16:183-197.
316. Moore BR, Krakowka S, Robertson JT Cytologic evaluation of bronchoalveolar lavage fluid obtained from standardbred racehorses with inflammatory airway disease. Am J Vet Res 1995, 56:562-567.
317. Moore BR, Krakowka S, Cummins JM, et al. Changes in airway inflammatory cell populations in standardbred racehorses after interferon-alpha administration. Vet Immunol Immunopathol 1996, 49:347-358.
318. Moore BR, Krakowka S, McVey DS, et al. Inflammatory markers in bronchoalveolar lavage fluid of standardbred racehorses with inflammatory airway disease: response to interferon-alpha. Equine Vet J 1997, 29:142-147.
319. Zinkl JG, Madigan JE, Fridmann DM, et al. Haematological, bone marrow and clinical chemical changes in neonatal foals given canine recombinant granulocyte-colony stimulating factor. Equine Vet J 1994, 26:313-318.
320. Madigan JE, Zinkl JG, Fridmann DM, et al. Preliminary studies of recombinant bovine granulocyte-colony stimulating factor on haematological values in normal neonatal foals. Equine Vet J 1994, 26:159-161.
321. Audibert FM, Lise LD Adjuvants: current status, clinical perspectives and future prospects. Trends Pharmacol Sci 1993, 14:174-178.
322. Flaminio MJ, Rush BR, Shuman W Immunologic function in horses after non-specific immunostimulant administration. Vet Immunol Immunopathol 1998, 63:303-315.
323. Hacker G, Redecke V, Hacker H Activation of the immune system by bacterial CpG-DNA. Immunology 2002, 105:245-251.
324. Rankin R, Pontarollo R, Ioannou X, et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001, 11:333-340.
325. Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996, 273:352-354.
326. Whitmore MM, Li S, Falo L, et al. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol Immunother 2001, 50:503-514.
327. Ziebell KL, Steinmann H, Kretzdorn D, et al. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses. Zentralbl Veterinarmedizin-Reihe B 1997, 44:529-536.
328. Studer U, Marti E, Stornetta D, et al. [The therapy of equine sarcoid with a non-specific immunostimulator: the epidemiology and spontaneous regression of sarcoids]. Schweiz Arch Tierheilkd/Sat, Schweiz Arch Tierheilkd 1997, 139:385-391.
329. O'Neill W, McKee S, Clarke AF Immunological and haematinic consequences of feeding a standardised Echinacea ( Echinacea angustifolia) extract to healthy horses. Equine Vet J 2002, 34:222-227.
330. Babiuk LA, Misra V Levamisole and bovine immunity: in vitro and in vivo effects on immune responses to herpesvirus immunization. Can J Microbiol 1981, 27:1312-1319.
331. Roth JA, Kaeberle ML Effect of levamisole on lymphocyte blastogenesis and neutrophil function in dexamethasone-treated cattle. Am J Vet Res 1984, 45:1781-1784.
332. Lunn DP, Townsend HGG Equine vaccination. Vet Clin North Am Equine Pract 2000, 16:199-226.
333. Macy DW Vaccine adjuvants. Semin Vet Med Surg Small Anim 1997, 12:206-211.
334. Savage CJ Diseases of the liver. Equine medicine and surgery 1999, Mosby, St. Louis. J. Moore (Ed.).
335. Janeway CA, Travers P, Walport M, et al. Allergy and hypersensitivity. Immunobiology 2002, Garland Publishing, New York.
336. Jose-Cunilleras E, Kohn CW, Hillier A, et al. Intradermal testing in healthy horses and horses with chronic obstructive pulmonary disease, recurrent urticaria, or allergic dermatitis. J Am Vet Med Assoc 2001, 219:1115-1121.
337. DeBoer DJ Survey of intradermal skin testing practices in North America. J Am Vet Med Assoc 1989, 195:1357-1363.
338. Barbet JL, Bevier D, Greiner EC Specific immunotherapy in the treatment of Culicoides hypersensitive horses: a double-blind study. Equine Vet J 1990, 22:232-235.
339. Schmid-Grendelmeier P, Crameri R Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001, 125:96-111.
340. Crameri R High throughput screening: a rapid way to recombinant allergens. Allergy 2001, 56:30-34.
341. Jahn-Schmid B, Wiedermann U, Bohle B, et al. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 1999, 104:1015-1023.
342. Broide D, Raz E DNA-Based immunization for asthma. Int Arch Allergy Immunol 1999, 118:453-456.
343. Broide D, Schwarze J, Tighe H, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998, 161:7054-7062.